Specialty Laboratories Names Chief Executive
- Share via
Specialty Laboratories Inc., a maker of laboratory tests, named Douglas Harrington as chief executive. Harrington, 48, had been interim CEO after James Peter resigned last month.
Specialty is appealing a government decision last month to revoke its license, alleging that laboratory services had been performed by unlicensed staff.
Harrington has served on the Specialty board since 1996. He also is chairman of medical device maker ChromaVision Medical Systems Inc. and a clinical pathology professor at the USC Keck School of Medicine.
Specialty shares rose 14 cents to $7.99 on the New York Stock Exchange.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
